We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

AMRX Amneal Pharmaceuticals Holding Co

0.24 (5.57%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,508,219
Bid Price
Ask Price
News (3)
Day High 4.69


52 Week Range


Day Low 4.25
Company Name Stock Ticker Symbol Market Type
Amneal Pharmaceuticals Holding Co AMRX NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.24 5.57% 4.55 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.36 4.25 4.69 4.66 4.31
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,538 1,508,219 $ 4.57 $ 6,889,715 - 1.24 - 4.74
Last Trade Time Type Quantity Stock Price Currency
19:00:00 160,951 $ 4.66 USD

Amneal Pharmaceuticals Holding Co Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.43B 306.54M - 2.22B -129.99M -0.42 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Amneal Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No AMRX Message Board. Create One! See More Posts on AMRX Message Board See More Message Board Posts

Historical AMRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.484.694.164.311,135,6430.071.56%
1 Month4.214.693.964.331,130,0090.348.08%
3 Months3.704.693.364.101,270,9790.8522.97%
6 Months2.344.742.273.731,201,7472.2194.44%
1 Year2.574.741.242.921,165,2751.9877.04%
3 Years4.017.4451.243.951,072,8340.5413.47%
5 Years17.9918.401.244.671,303,513-13.44-74.71%

Amneal Pharmaceuticals Description

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |